WHO classification salivary tumours: What's new?
|
|
- Stephany Watson
- 6 years ago
- Views:
Transcription
1 WHO classification salivary tumours: What's new? Alena Skalova, MD, PhD Professor of Pathology Charles University, Faculty of Medicine in Plzen, Czech Republic An update on Histopathology of Salivary Gland Tumors, La Spezia, Italy, Oct 18-20, 2017
2
3
4 WHO classification of salivary tumours 1972
5 Revised WHO classification 1991
6 WHO classification 2005
7 WHO ConsensusMeeting 2016
8 WHO Classification ofsalivary Gland Tumors2017
9 WHO Classification ofsalivary Gland Tumors2017
10 Mammary analogue secretory carcinoma (MASC) Intraductal carcinoma Cribriform adenocarcinoma of tongue (CATS/CASG) Sclerosing polycystic adenoma (SPA)
11 (MammaryAnalogue) Secretory Carcinoma(MASC)
12 (Mammary analogue)secretory carcinoma(masc) akin to secretory carcinoma of the breast, MASC expresses CK7/S-100 protein, and mammaglobin harbours t(12;15)(p13;q25) translocation resulting in ETV6-NTRK3 fusion presence of t(12;15) was not demonstrated in any other salivary gland tumor o however, many fusion partners of ETV6 have been reported in a variety of epithelial and hematological malignancies other than salivary
13
14 Secretory carcinoma (mammary analogue) ETV6-NTRK3 ETV6-RET (ETV6-X) Skalova et al. AmJ SurgPathol2010; 34:
15 Secretory Carcinoma (mammary analogue) MASC Low grade vesicular nuclei, centrally located nucleolus, pink vacuolated cytoplasm
16 FISH foretv6gene breakis positive FISH analysis of ETV6 gene (12p13) using break apart rearrangement probe - Vysis ETV6 Break Apart FISH Probe Kit (Abbott Molecular) in FFPE tissue. Nuclei with one fusion (yellow), one orange, and one green (split) signal pattern indicative of a rearrangement of one copy of theetv6gene region.
17 Less common and unexpected features in MASC
18 Masked MASC of parotid gland Petersson et al. A New Hitherto Unreported Histopathologic Manifestation of Mammary Analogue Secretory Carcinoma: Masked MASC Associated With Low-grade Mucinous Adenocarcinoma and Low-grade In Situ Carcinoma Components. Appl Immunohistochem Mol Morphol, in press
19 Lesscommonand unexpected featuresin MASC salivary gland tumor of the parotid gland in a 54- year-old woman which contained a minor mammary analogue secretory carcinoma (MASC) component (20%) intermixed with a different mucinous adenocarcinoma component (80%) morphologically nondescript low-grade intraductal carcinoma (in situ) component Both of the components revealed ETV6 rearrangement, RT-PCR failed to reveal an ETV6- NTRK3 fusion
20 MASC with mucinous adenocarcinoma component S100 protein positive in MASC component
21 Mucinous MASC with with macrocysticappearance mucinous MASC of parotid gland in 17-y old male with a macrocystic appearance should not be mistaken for low-grade MEC the cells of MASC can have single cytoplasmic vacuole thus mimicking mucous cells Macrocystic structures lined by single layer of apocrine cells with only rare, multivacuolated cells more characteristic of MASC S100/MMG stain and ETV6 gene rearrangement, RT- PCR failed to reveal an ETV6-NTRK3 fusion
22 Mucinous MASC MASC with prevailing macrocystic growth pattern
23 Mucinous MASC MASC with macrocystic appearance and apocrine features
24 Sclerotic MASC MASC with ETV6-X fusion
25 Sclerotic MASC MASC with ETV6-X fusion: prominent fibrosclerotic stroma
26 Mammary Analogue Secretory Carcinoma of Salivary Glands with High-grade Transformation HG-MASC with atypical ETV6/NTRK3 fusion
27 Mammary Analogue Secretory Carcinoma of Salivary Glands with High-grade Transformation Skalova et al. Am J Surg Pathol 2014;38:23-33
28 Molecular Features of MASC most SCs harbor the recurrent balanced t(12;15) (p13;q25) chromosomal rearrangement resulting in the fusion of the ETV6 and NTRK3 genes the ETV6 gene split visualized by FISH the classical ETV6-NTRK3 fusion transcript (exon 5- exon 15 junction) is in some cases not detected by standard reverse-transcriptase polymerase chain reaction (RT-PCR) atypical fusion transcripts (4-14 or 5-14 junctions) ETV6-RET fusion
29 25 cases FISH ETV6 positive, RT-PCR negative Nested RT-PCR positive in 4 16/25 rearrangement of NTRK3 4 cases of MASC ETV6-X gene fusion
30 Secretory carcinoma (MASC) with ETV6-X translocation MASC with ETV6-X fusion, predominatly macrocystic and papillary structures
31 Secretory carcinoma (MASC) with ETV6-X translocation SC with prominent hyalinization and trabeculae of neoplastic cellsembedded in a completely hyalinized central part
32 Molecular profiling of mammary analogue secretory carcinoma revealed a subset of tumors harboring a novel ETV6-RET translocation: report of 10 cases The presence of ETV6-RET fusion in MASC was proved by at least three independent tests, i.e. NGS, FISH, RT-PCR Histomorphology is variable MASC patients with ETV6-RET fusions may benefit from RET-targeted therapy o Skalova et al. AmJ SurgPatholAug2017, in press
33 Secretory carcinoma (MASC) with novel ETV6-RET translocation SC with typical morphology and immunoprofile harboring a novel ETV6-RET translocation (4 cases)
34 Secretory carcinoma (MASC) with novel ETV6-RET translocation predominantly multicystic growth pattern with multiple mural nodules (3 cases)
35 Secretory carcinoma (MASC) with novel ETV6-RET translocation prominent fibrosclerotic stroma with isolated tumor cells in small islands or trabeculae (3 cases)
36 Primary extrasalivary MASC
37 PrimaryMASC ofthyroidgland ETV6-NTRK3 fusion was found in about 14% of radiation-induced well-differentiated papillary thyroid carcinomas Leeman-Neil, et al. Cancer 2014;120: In up to 2% of sporadic well-differentiated papillary thyroid carcinomas Primary MASC of the thyroid masquerading as papillary thyroid cancer Reynolds, et al. Head Neck Pathol 2016;10: Primary thyroid MASC Stevens, et al. Modern Pathol 2015;28: Dettloff, et al Head Neck Pathol 2017;11(2):
38 PrimaryMASC ofthe thyroid gland two cases of papillary carcinoma of the thyroid, which showed transitions to the MASC papillary carcinoma component of the thyroid was TTF1 and thyroglobulin positive, MASC component was negative on these thyroid markers and was mammaglobin, S-100, p63, PAX8, GCDFP-15 positive Both of the components of this composite tumors revealed ETV6 rearrangement Dogan,et al.mammary analogue secretory carcinoma of the thyroid gland: A primary thyroid adenocarcinoma harboring ETV6-NTRK3 fusion. Modern Pathol 2016;29:
39 Primary composite MASC of thyroid gland Papillary thyroid carcinoma component of MASC
40 Primary composite MASC of thyroid gland conventional MASC component
41 Treatmentof MASC treatment of MASC has varied, ranging from simple excision to radical resection, neck dissection, adjuvant radiotherapy, and/or adjuvant systemic chemotherapy For patients presenting with a locally advanced, recurrent or metastatic disease the treatment options are currently limited and mainly palliative Testing foretv6-ntrk3 translocation-pan TrK inhibitor Entrectinib(Ignyta) targets NTRK, ROS1, and ALK fusions ETV6-RET testing Drilon et al. What hides behind MASC: Ann Oncol 2016;27:920-6
42 TargetedtreatmentofMASC Use of and response to tyrosine kinase inhibitors in SC is limited, so far recent study suggested that the inhibition of ETV6-NTRK3 activation could be used for the treatment of patients with this fusion DrilonA, Li G, DoganS, et al. What hides behind the MASC: clinical response and acquired resistance to entrectinibafter ETV6-NTRK3 identification in a mammary analogue secretory carcinoma (MASC). Ann Oncol. 2016;27:
43 Conclusions; Secretorycarcinoma MASC has distinctive morphology and immunoprofile in most cases Diagnosis of classical MASC features could be performed without molecular testing However, in cases that depart from the typical features of MASC in some way Molecular testing in MASC is of potential value in treatment of patients
44 Draft WHO classification 2017
45 CribriformAdenocarcinoma of Tongue (CAT) and (other) SalivaryGlands (CASG) Michal et al. Cribriform adenocarcinoma of the tongue. Histopathology 1999;35:
46
47 Possiblevariant of PLGA is CAT/CASG, but it isnot yet clear whether this represents a genuine entity or just an unusual growth pattern in PLGA. WHO Classification of Tumours: Pathology and Genetics Head and Neck Tumours, IARC Press, 2005
48 Polymorphousadenocarcinoma (PAC)- WHO 2017 Syn. Low-grade polymorphous adenocarcinoma (PLGA); terminal duct carcinoma; lobular carcinoma CATS/CAMSG considered as cribriform variant of PAC FonsecaI; AssaadA; KatabiN; SeethalaR; Simpson RHW; Skálová A;Weinreb I; Wenig B
49 Polymorphous (low-grade) adenocarcinoma(plga/pac) Spindle shaped cells, streaming Perineural invasion Targetoid structures Regular nuclei
50 CribriformAdenocarcinoma of Tongue and SalivaryGlands (CATS/CASG)
51 CASG; solid and cribriform structures
52 CASG overlapping clear, grooved nuclei Papillary growth pattern, ground-glass nuclei
53 Key Featuresdistinguishing PLGA versus CASG PLGA is a low-grade infiltrative malignancy with a mixture of tubular, cribriform, papillary, and solid growth, arranged in fascicles with targetoid neurotropism CASG is a tumor with distinctive cribriform/papillary glomeruloid patterns and highly vesicular papillary thyroid carcinoma like nuclei predominating in base of tongue PLGAs are characterized by PRKD1 E710D mutations, whereas CASGs are characterized by PRKD1-3 translocations CASGs have a high capacity for nodal spread
54 Conclusions; CASG Histologic and molecular overlap between CASG and PLGA CASG is a distinct tumor entity, differs from PLGA by location, cytology, histological architecture, and behavior frequent lymph node metastasis at the time of presentation Paradoxically, early metastatic disease is associated with an indolent behavior It makes CASG a unique neoplasm among all lowgrade salivary gland tumors
55 Draft WHO classification 2017.
56 Intraductal carcinoma Syn. cribriform cystadenocarcinoma; intraductal carcinoma, low-grade; low-grade SDC Solid, cystic, in situ Mostly parotid gland Excellent prognosis Loening T; Leivo I; Simpson RHW; Weinreb I CK14
57 Intraductalcarcinoma(IC) IC show a variety of growth patterns, both solid and cystic, ranging from cribriform to solid to micropapillary reminiscent of low-grade ductal carcinoma in situ or atypical ductal hyperplasia of the breast. Tumor cells are monomorphic and ovoid and evenly spaced with round nuclei and scant eosinophilic cytoplasm. Oncocytic and apocrine change and intermediate grade cytonuclear features are uncommon.
58
59
60
61 p63
62 mammaglobin
63 S100 protein
64 S100 protein
65 S100 Calponin AR
66 S100 Apocrine variant of IDC AR
67 Intraductalcarcinoma; conclusions Pure intraductal lesions with either intercalated duct or mixed apocrine/intercalated duct morphology and S100 positivity should be called intraductal carcinoma they rarely invade and are associated with good outcome after excision Pure apocrine equivalents are generally invasive and are likely more related to true SDC and are better termed SDC in-situ or in-situ and microinvasive SDC these should be treated as if they could behave like fully invasive SDC
68 Draft WHO classification 2017.
69 SclerosingPolycysticAdenosis/ Adenoma (SPA) Smith BC, Ellis GL, Slater LJ, Foss RD, Sclerosingpolycystic adenosisof major salivary glands. A clinicopathologic analysis of nine cases. Am J Surg Pathol 1996:20:
70 Sclerosingpolycystic adenosis (SPA) Synonymum: sclerosing polycystic adenoma o Benign neoplasm o Recurrences common o Clonal by HUMARA o Dysplasia, DCIS, carcinoma arising in
71 Sclerosing polycystic adenoma Circumscribed lesion, embedded in parotid gland
72 Sclerosing polycystic adenoma Well circumscribed, with multiple variably sized cystic ducts
73 Ducts lined by flattened to cuboidal epithelium with apocrine and foamy change
74
75 Dysplastic epithelium/ DCIS like
76 Sclerosing polycystic adenoma CK14
77 Biological natureand behavior of SPA All but one reported cases of SPA are benign recurrence occurs in about one-third of cases lesion may be multifocal, difficult treatment focal atypical hyperplasia and DCIS in most cases infiltrative foci mimicking intra-lesional invasive adenocarcinoma invasive carcinoma arising in SPA Manajlovic et al. Pathol Res Pract 2014; Marques et al. Virchows Arch 2014;464:
78 Differentialdiagnosis and management of patientswithspa Both benign and malignant conditions sclerosing sialadenitis, polycystic dysgenetic disease, PA, LG cystadenocarcinoma, AciCCa, mucoepidermoid carcinoma management is surgical with conservative subtotal parotidectomy prolonged surveillance High risk of recurrences very low risk of carcinomatous transformation
79 Conclusions; SPA is a distinctive entity, rare neoplastic condition with characteristic histologic features, Atypical hyperplasia, dysplasia, DCIS Evidence of clonality (HUMARA assay) Frequent recurrences, including multiple Report of invasive carcinoma ex SPA No metastases, no DOD so far Skalova, et al. Virchows Arch 2002;440: Skalova, et al. Am J Surg Pathol 2006;30:
80 2017 WHO Classificationof salivarytumors;conclusions Useful summary of present knowledge Includes new entities, such as MASC/Secretory carcinoma Good to include Other epithelial lesions Improves the section on undifferentiated and neuroendocrine carcinomas Improves the section on low-grade SDC by including intraductal carcinoma Polymorphous adenocarcinoma is confusing I would have preferred to keep PLGA and include CATS as a separate entity.
81 Thank you for attention An update on Histopathology ofsalivary Gland Tumors, La Spezia, Italy, Oct 18-20, 2017
New/Emerging Entities in Salivary Gland Pathology
New/Emerging Entities in Salivary Gland Pathology Alena Skalova, MD, PhD Professor of Pathology Charles University, Faculty of Medicine in Plzen, Czech Republic 2018 IAP Congress; Jordan, 14 18 October
More informationDiagnostically relevant molecular alterations in salivary glandtumours
Diagnostically relevant molecular alterations in salivary glandtumours Alena Skalova, MD, PhD Professor of Pathology Charles University, Faculty of Medicine in Plzen, Czech Republic An update on Histopathology
More informationPRELIMINARY CYTOLOGIC DIAGNOSIS: Suspicious for Acinic Cell Carcinoma. Cell Block: Immunohistochemical Studies CYTOLOGIC DIAGNOSIS:
1 PRELIMINARY CYTOLOGIC DIAGNOSIS: Suspicious for Acinic Cell Carcinoma. Cell Block: Immunohistochemical Studies GCDFP-15 S-100 CYTOLOGIC DIAGNOSIS: Consistent with mammary analogue secretory carcinoma.
More informationWHO 2017: New Classification of Head and Neck Tumours
WHO 2017: New Classification of Head and Neck Tumours Ilmo Leivo Department of Pathology University of Turku & Turku University Hospital FINLAND Suomen IAP Aulanko 18.05.2018 WHO 2017 New entities Simplification
More informationSalivary gland neoplasms: an update 29th Annual Meeting of Arab Division of the International Academy of Pathology MUSCAT, OMAN 2017
Salivary gland neoplasms: an update 29th Annual Meeting of Arab Division of the International Academy of Pathology MUSCAT, OMAN 2017 Dr Mary Toner Consultant Pathologist St James Hospital Trinity College
More informationEvening Specialty Conference: Cytopathology
: Cytopathology N. Paul Ohori, M.D. University of Pittsburgh Medical Center Disclosure of Relevant Financial Relationships Disclosure of Relevant Financial Relationships USCAP requires that all planners
More informationUpdate in Salivary Gland Pathology. Benjamin L. Witt University of Utah/ARUP Laboratories February 9, 2016
Update in Salivary Gland Pathology Benjamin L. Witt University of Utah/ARUP Laboratories February 9, 2016 Objectives Review the different appearances of a selection of salivary gland tumor types Establish
More informationMammary analogue secretory carcinoma of salivary gland A case report of new entity
Case Report Mammary analogue secretory carcinoma of salivary gland A case report of new entity Vaibhav Bhika Bari 1*, Sandhya Unmesh Bholay 2 1 Assistant Professor, 2 Associate Professor Rajiv Gandhi Medical
More informationOncocytic-Appearing Salivary Gland Tumors. Oncocytic, Cystic, Mucinous, and High Grade Salivary Gland Tumors SALIVARY GLAND FNA: PART II
William C. Faquin, MD, PhD Professor of Pathology Harvard Medical School Director of Head and Neck Pathology Massachusetts Eye and Ear Massachusetts General Hospital SALIVARY GLAND FNA: PART II Oncocytic,
More information5/22/2017. An Aggressive Nasopharyngeal Tumor. Case History
An Aggressive Nasopharyngeal Tumor Head & Neck/Endocrine Evening Specialty Conference Martin Bullock, MD, FRCPC Dalhousie University, Halifax, Nova Scotia Case History 52-year-old male, 6 month history
More information04/09/2018. Salivary Gland Pathology in the Molecular Era Old Friends, Old Foes, & New Acquaintances
Salivary Gland Pathology in the Molecular Era Old Friends, Old Foes, & New Acquaintances Jennifer L. Hunt, MD, MEd Aubrey J. Hough Jr, MD, Endowed Professor of Pathology Chair of Pathology and Laboratory
More informationARIZONA SOCIETY OF PATHOLOGISTS 13 TH APRIL 2013 HEAD AND NECK CYTOPATHOLOGY. F ZAHRA ALY, MD, PhD
ARIZONA SOCIETY OF PATHOLOGISTS 13 TH APRIL 2013 HEAD AND NECK CYTOPATHOLOGY F ZAHRA ALY, MD, PhD The main areas sites amenable for cytopathology include lymph nodes, thyroid, major salivary glands especially
More informationEnterprise Interest None
Enterprise Interest None What are triple negative breast cancers? A synopsis of their histological patterns Ian Ellis Molecular Medical Sciences, University of Nottingham Department of Histopathology,
More informationMolecular Diagnostics of Head and Neck Tumors Justin A. Bishop, M.D. Associate Professor of Pathology The Johns Hopkins University Baltimore, Maryland
Molecular Diagnostics of Head and Neck Tumors Justin A. Bishop, M.D. Associate Professor of Pathology The Johns Hopkins University Baltimore, Maryland Two Main Topics Molecular insights in salivary gland
More informationObjectives. Salivary Gland FNA: The Milan System. Role of Salivary Gland FNA 04/26/2018
Salivary Gland FNA: The Milan System Dr. Jennifer Brainard Section Head Cytopathology Cleveland Clinic Objectives Introduce the Milan System for reporting salivary gland cytopathology Define cytologic
More informationFine-Needle Aspiration Cytology of Low-Grade Cribriform Cystadenocarcinoma with Many Psammoma Bodies of the Salivary Gland
The Korean Journal of Pathology 2013; 47: 481-485 CASE STUDY Fine-Needle Aspiration Cytology of Low-Grade Cribriform Cystadenocarcinoma with Many Psammoma Bodies of the Salivary Gland Ji Yun Jeong Dongbin
More informationPapillary Lesions of the breast
Papillary Lesions of the breast Emad Rakha Professor of Breast Pathology The University of Nottingham Papillary lesions of the breast are a heterogeneous group of disease, which are characterised by neoplastic
More informationSalivary Glands 3/7/2017
Salivary Glands 3/7/2017 Goals and objectives Focus on the entities unique to H&N Common board type facts Information for your future practice Salivary Glands Salivary Glands Major gland. Paratid. Submandibular.
More informationReview and Updates of Immunohistochemistry in Selected Salivary Gland and Head and Neck Tumors
Review and Updates of Immunohistochemistry in Selected Salivary Gland and Head and Neck Tumors. Monophasic tumors : myoepithelioma, acinic cell carcinoma, and salivary duct carcinoma. Biphasic tumors includes
More informationCarcinoma mammario: le istologie non frequenti. Valentina Guarneri Università di Padova IOV-IRCCS
Carcinoma mammario: le istologie non frequenti Valentina Guarneri Università di Padova IOV-IRCCS Histological diversity of breast adenocarcinomas Different histological types are defined according to specific
More informationDisclosure. Relevant Financial Relationship(s) None. Off Label Usage None MFMER slide-1
Disclosure Relevant Financial Relationship(s) None Off Label Usage None 2013 MFMER slide-1 Case Presentation A 43 year old male, with partial nephrectomy for a right kidney mass 2013 MFMER slide-2 2013
More informationSalivary gland tumor cytologic and histologic correlation: Algorithmic and risk stratification based approaches
Salivary gland tumor cytologic and histologic correlation: Algorithmic and risk stratification based approaches Christopher C. Griffith, MD, PhD Raja R. Seethala, MD 1. Salivary gland tumor cytology: A
More informationA 60-year old Man with Left Jaw Mass. Simon Chiosea, MD University of Pittsburgh medical Center 3/15/2016
ACCME/Disclosures The USCAP requires that anyone in a position to influence or control the content of CME disclose any relevant financial relationship WITH COMMERCIAL INTERESTS which they or their spouse/partner
More informationSalivary Gland Cytology
Salivary Gland Cytology Diagnostic challenges and potential pitfalls Tarik M. Elsheikh, MD Professor and Medical Director Anatomic Pathology Cleveland Clinic FNA Salivary Gland Lesions Indications Distinguish
More informationLesions Mimicking Adenoid Cystic Carcinoma. Diagnostic Problems in Salivary Gland Pathology An Update 5/29/2009
Diagnostic Problems in Salivary Gland Pathology An Update Lesions Mimicking Adenoid Cystic Carcinoma Stacey E. Mills, M.D. W.S. Royster Professor of Pathology Director of Surgical and Cytopathology University
More informationSalivary Gland Neoplasms. Napa Valley Pathology Conference Silverado Resort & Spa May 18, /22/2018. Salivary Gland Neoplasms Outline
Salivary Gland Neoplasms Napa Valley Pathology Conference Silverado Resort & Spa May 18, 2018 Bruce M. Wenig, MD Moffitt Cancer Center Tampa, FL Salivary Gland Neoplasms Outline Basic concepts of salivary
More informationSalivary Gland Neoplasms. Salivary Gland Neoplasms Outline 4/16/2018. MUSC Pathology Multi-Specialty Course Kiawah Island, SC April 19, 2018
Salivary Gland Neoplasms MUSC Pathology Multi-Specialty Course Kiawah Island, SC April 19, 2018 Bruce M. Wenig, MD Moffitt Cancer Center Tampa, FL Salivary Gland Neoplasms Outline Basic concepts of salivary
More information04/10/2018. Intraductal Papillary Neoplasms Of Breast INTRADUCTAL PAPILLOMA
Intraductal Papillary Neoplasms Of Breast Savitri Krishnamurthy MD Professor of Pathology Deputy Division Head The University of Texas MD Anderson Cancer Center 25 th Annual Seminar in Pathology Pittsburgh,
More informationHistological Type. Morphological and Molecular Typing of breast Cancer. Nottingham Tenovus Primary Breast Cancer Study. Survival (%) Ian Ellis
Morphological and Molecular Typing of breast Cancer Ian Ellis Molecular Medical Sciences, University of Nottingham Department of Histopathology, Nottingham University Hospitals NHS Trust Histological Type
More informationPapillary Lesions of the Breast A Practical Approach to Diagnosis. (Arch Pathol Lab Med. 2016;140: ; doi: /arpa.
Papillary Lesions of the Breast A Practical Approach to Diagnosis (Arch Pathol Lab Med. 2016;140:1052 1059; doi: 10.5858/arpa.2016-0219-RA) Papillary lesions of the breast Span the spectrum of benign,
More informationBasement membrane in lobule.
Bahram Memar, MD Basement membrane in lobule. Normal lobule-luteal phase Normal lobule-follicular phase Lactating breast Greater than 95% are adenocarcinomas in situ carcinomas and invasive carcinomas.
More informationA Cutaneous Facial Mass Identified as the New Entity Mammary Analogue Secretory Carcinoma of Probable Salivary Gland Origin
A Cutaneous Facial Mass Identified as the New Entity Mammary Analogue Secretory Carcinoma of Probable Salivary Gland Origin Scott W. Binder, MD Professor and Senior Vice Chair Chief, Dermatopathology Geffen/UCLA
More informationBreast pathology. 2nd Department of Pathology Semmelweis University
Breast pathology 2nd Department of Pathology Semmelweis University Breast pathology - Summary - Benign lesions - Acute mastitis - Plasma cell mastitis / duct ectasia - Fat necrosis - Fibrocystic change/
More informationCASE REPORT Malignant transformation of breast ductal adenoma: a diagnostic pitfall
Malaysian J Pathol 2015; 37(3) : 281 285 CASE REPORT Malignant transformation of breast ductal adenoma: a diagnostic pitfall Hiroko HAYASHI, Hiroshi OHTANI,* Junzo YAMAGUCHI,** and Isao SHIMOKAWA Department
More informationDifferential Diagnosis of Oral Masses. Palatal Lesions
Differential Diagnosis of Oral Masses Palatal Lesions Palatal Masses Periapical Abscess Torus Palatinus Mucocele Lymphoid Hyperplasia Adenomatous Hyperplasia Benign Salivary Neoplasms Malignant Salivary
More informationCase 1. ACCME/Disclosure. Clinical History. Dr. Mulligan has nothing to disclose
Breast Evening Specialty Conference USCAP, 2016 Case 1 Anna Marie Mulligan University Health Network, Toronto University of Toronto ACCME/Disclosure Dr. Mulligan has nothing to disclose Clinical History
More informationSelect problems in cystic pancreatic lesions
Disclosure Select problems in cystic pancreatic lesions Five Prime Therapeutics shareholder Adicet Bio shareholder Bristol-Meyer Squibb advisory board grace.kim@ucsf.edu Pancreatic cystic lesions Intraductal
More informationProliferative Breast Disease: implications of core biopsy diagnosis. Proliferative Breast Disease
Proliferative Breast Disease: implications of core biopsy diagnosis Jean F. Simpson, M.D. Breast Pathology Consultants, Inc. Nashville, TN Proliferative Breast Disease Must be interpreted in clinical and
More informationPapillary Lesions of the Breast: WHO Update
Papillary Lesions of the Breast: WHO Update Stuart J. Schnitt, M.D. Department of Pathology Beth Israel Deaconess Medical Center and Harvard Medical School Boston, MA, USA Papillary Lesions of the Breast
More informationProliferative Epithelial lesions of the Breast. Sami Shousha, MD, FRCPath Charing Cross Hospital & Imperial College, London
Proliferative Epithelial lesions of the Breast Sami Shousha, MD, FRCPath Charing Cross Hospital & Imperial College, London Amman, November2013 Proliferative Epithelial Lesions of the Breast Usual type
More informationUSCAP 2012: Companion Meeting of the AAOOP. Update on lacrimal gland neoplasms: Molecular pathology of interest
USCAP 2012: Companion Meeting of the AAOOP Vancouver BC, Canada, March 17, 2012 Update on lacrimal gland neoplasms: Molecular pathology of interest Valerie A. White MD, MHSc, FRCPC Department of Pathology
More informationSalivary Gland FNA ATYPICAL : Criteria and Controversies
Salivary Gland FNA ATYPICAL : Criteria and Controversies W.C. Faquin, M.D., Ph.D. Director, Head and Neck Pathology Massachusetts General Hospital Massachusetts Eye and Ear Infirmary Harvard Medical School
More informationDisclosure of Relevant Financial Relationships
Squamous entities of the thyroid: Reactive to Neoplastic Michelle D. Williams Associate Professor Dept of Pathology, Head & Neck Section University of Texas MD Anderson Cancer Center Disclosure of Relevant
More informationCase year old female presented with asymmetric enlargement of the left lobe of the thyroid
Case 4 22 year old female presented with asymmetric enlargement of the left lobe of the thyroid gland. No information available relative to a prior fine needle aspiration biopsy. A left lobectomy was performed.
More informationCase 4 Diagnosis 2/21/2011 TGB
Case 4 22 year old female presented with asymmetric enlargement of the left lobe of the thyroid gland. No information available relative to a prior fine needle aspiration biopsy. A left lobectomy was performed.
More information1 NORMAL HISTOLOGY AND METAPLASIAS
1 NORMAL HISTOLOGY AND METAPLASIAS, MD Anatomy and Histology 1 Metaplasias 2 ANATOMY AND HISTOLOGY The female breast is composed of a branching duct system, which begins at the nipple with the major lactiferous
More informationCytokeratin immunoprofile of primary and metastatic adenoid cystic carcinoma of salivary glands: a report of two cases
Article / Clinical Case Report Cytokeratin immunoprofile of primary and metastatic adenoid cystic carcinoma of salivary glands: a report of two cases Cibele Pidorodeski Nagano a, Cláudia Malheiros Coutinho-Camillo
More informationLos Angeles Society Of Pathologists Dr. Shobha Castelino Prabhu
Los Angeles Society Of Pathologists Dr. Shobha Castelino Prabhu Loma Linda University Medical Center June 12, 2007 CASE 1 76 year-old gentleman Status post right parotidectomy 1 year ago for a rare tumor
More informationPROSTATIC ADENOCARCINOMA: DIAGNOSTIC CRITERIA AND IMPORTANT MIMICKERS PROSTATIC ADENOCARCINOMA: DIAGNOSTIC CRITERIA
PROSTATIC ADENOCARCINOMA: DIAGNOSTIC CRITERIA AND IMPORTANT MIMICKERS PROSTATIC ADENOCARCINOMA: DIAGNOSTIC CRITERIA 1 A good H & E helps! ADENOCARCINOMA DIAGNOSTIC CRITERIA Relatively uniform proliferation
More informationOncocytic carcinoma: A rare malignancy of the parotid gland
ISPUB.COM The Internet Journal of Pathology Volume 8 Number 2 Oncocytic carcinoma: A rare malignancy of the parotid gland K Mardi, J Sharma Citation K Mardi, J Sharma.. The Internet Journal of Pathology.
More informationNotice of Faculty Disclosure
California Society of Pathology Diagnostic Problems in Surgical Pathology December 2015 Case 2 Laura C. Collins, M.D. Associate Professor of Pathology Associate Director of Anatomic Pathology Beth Israel
More informationPapillary Lesions of the Breast
Papillary Lesions of the Breast Laura C. Collins, M.D. Associate Professor of Pathology Associate Director, Division of Anatomic Pathology Beth Israel Deaconess Medical Center and Harvard Medical School
More informationUniversity Journal of Pre and Para Clinical Sciences
ISSN 2455 2879 Volume 2 Issue 1 2016 Metaplastic carcinoma breast a rare case report Abstract : Metaplastic carcinoma of the breast is a rare malignancy with two distinct cell lines described as a breast
More informationSlide seminar. Asist. Prof. Jože Pižem, MD, PhD Institute of Pathology Medical Faculty, University of Ljubljana
Slide seminar Asist. Prof. Jože Pižem, MD, PhD Institute of Pathology Medical Faculty, University of Ljubljana Case 5 A 57-year-old man with a dermal/subcutaneous lesion on the scalp, which was interpreted
More informationA712(18)- Test slide, Breast cancer tissues with corresponding normal tissues
A712(18)- Test slide, Breast cancer tissues with corresponding normal tissues (formalin fixed) For research use only Specifications: No. of cases: 12 Tissue type: Breast cancer tissues with corresponding
More informationLow-grade cribriform cystadenocarcinoma arising from a minor salivary gland: a case report
145 Journal of Oral Science, Vol. 58, No. 1, 145-149, 2016 Case Report Low-grade cribriform cystadenocarcinoma arising from a minor salivary gland: a case report Masashi Kimura 1), Shinji Mii 2), Shinichi
More informationContents 1 The Windows of Susceptibility to Breast Cancer 2 The So Called Pre-Neoplastic Lesions and Carcinoma In Situ
Contents 1 The Windows of Susceptibility to Breast Cancer... 1 1.1 Introduction... 1 1.2 Risk Factor and Etiological Agents... 2 1.3 The Concept of the Windows of Susceptibility to Carcinogenesis... 5
More information4/17/2015. Case 1. A 37 year old man with a 2.2 cm solitary left thyroid mass.
Case 1 A 37 year old man with a 2.2 cm solitary left thyroid mass. Case 1 Case 1 1 Case 1: Diagnosis? A. Benign B. Atypia of undetermined significance/follicular lesion of undetermined significance C.
More informationSalivary gland carcinomas-update
Salivary gland carcinomas-update Alena Skalova, MD, PhD Professor of Pathology Charles University, Faculty of Medicine in Plzen, Czech Republic An update on Histopathology of Salivary Gland Tumors, La
More informationB. Environmental Factors. a. The major risk factor to papillary thyroid cancer is exposure to ionizing radiation, during the first 2 decades of life.
B. Environmental Factors. a. The major risk factor to papillary thyroid cancer is exposure to ionizing radiation, during the first 2 decades of life. b. Deficiency of dietary iodine: - Is linked with a
More informationCase Report Tumor-to-Tumor Metastasis: Lung Carcinoma Metastasizing to Thyroid Neoplasms
Hindawi Publishing Corporation Volume 2015, Article ID 153932, 5 pages http://dx.doi.org/10.1155/2015/153932 Case Report Tumor-to-Tumor Metastasis: Lung Carcinoma Metastasizing to Thyroid Neoplasms Shiuan-Li
More informationFlat Epithelial Atypia
Flat Epithelial Atypia Richard Owings, M.D. University of Arkansas for Medical Sciences Department of Pathology Flat epithelial atypia can be a difficult lesion May be a subtle diagnosis Lots of changes
More informationThey Do Look Alike : Mimics of Prostate Cancer in Biopsy Samples
They Do Look Alike : in Biopsy Samples Gladell P. Paner, MD Departments of Pathology and Surgery (Urology) University of Chicago, IL USA Gladell.paner@uchospitals.edu Benign in Needle Biopsy 1. Benign
More informationA712(19)- Test slide, Breast cancer tissues with corresponding normal tissues
A712(19)- Test slide, Breast cancer tissues with corresponding normal tissues (formalin fixed) For research use only Specifications: No. of cases: 12 Tissue type: Breast cancer tissues with corresponding
More informationPolymorphous Low-Grade. December 5 th, 2008
Polymorphous Low-Grade Adenocarcinoma December 5 th, 2008 Epidemiology Represents 2 nd or 3 rd most common minor salivary gland malignancy (17-26%) 1 st mucoepidermoid carcinoma Rare in reported Asian
More informationINTRADUCTAL LESIONS OF THE PROSTATE. Jonathan I. Epstein
INTRADUCTAL LESIONS OF THE PROSTATE Jonathan I. Epstein Topics Prostatic intraepithelial neoplasia (PIN) Intraductal adenocarcinoma (IDC-P) Intraductal urothelial carcinoma Ductal adenocarcinoma High Prostatic
More informationGross appearance of nodular hyperplasia in material obtained from suprapubic prostatectomy. Note the multinodular appearance and the admixture of
Tiền liệt tuyến Tiền liệt tuyến Gross appearance of nodular hyperplasia in material obtained from suprapubic prostatectomy. Note the multinodular appearance and the admixture of solid and microcystic areas.
More informationWhat is New in the 2015 WHO Lung Cancer Classification? Zhaolin Xu, MD, FRCPC, FCAP
What is New in the 2015 WHO Lung Cancer Classification? Zhaolin Xu, MD, FRCPC, FCAP Professor, Dept of Pathology, Dalhousie University, Canada Pulmonary Pathologist and Cytopathologist, QEII HSC Senior
More informationMy Journey into the World of Salivary Gland Sebaceous Neoplasms
My Journey into the World of Salivary Gland Sebaceous Neoplasms Douglas R. Gnepp Warren Alpert Medical School at Brown University Rhode Island Hospital Pathology Department Providence RI Asked to present
More informationSclerosing Polycystic Adenosis of Tongue
Bull Tokyo Dent Coll (2018) 59(2): 121 125 Case Report doi:10.2209/tdcpublication.2017-0029 Sclerosing Polycystic Adenosis of Tongue Paulo Henrique Braz-Silva 1,2), Alan Motta do Canto 3), Leticia Oliveira
More informationCase 2. Dr. Sathima Natarajan M.D. Kaiser Permanente Medical Center Sunset
Case 2 Dr. Sathima Natarajan M.D. Kaiser Permanente Medical Center Sunset History 24 year old male presented with a 3 day history of right flank pain, sharp in nature Denies fever, chills, hematuria or
More informationBreast Pathology. Breast Development
Breast Pathology Lecturer: Hanina Hibshoosh, M.D. Reading: Kumar, Cotran, Robbins, Basic Pathology, 6th Edition, pages 623-635 Breast Development 5th week - thickening of the epidermis - milk line 5th
More informationencapsulated thyroid nodule with a follicular architecture and some form of atypia. The problem is when to diagnose
Histological Spectrum of Papillary Carcinoma of Thyroid A Two Years Study Gomathi Srinivasan 1, M. Vennila 2 1 Associate Professor Pathology, Government Medical College, Omandurar Estate, Chennai 600 002
More informationCase Report Tumor-to-Tumor Metastasis: Lung Carcinoma Metastasizing to Thyroid Neoplasms
Case Reports in Pathology Volume 2015, Article ID 153932, 5 pages http://dx.doi.org/10.1155/2015/153932 Case Report Tumor-to-Tumor Metastasis: Lung Carcinoma Metastasizing to Thyroid Neoplasms Shiuan-Li
More informationUrinary Bladder: WHO Classification and AJCC Staging Update 2017
Urinary Bladder: WHO Classification and AJCC Staging Update 2017 Houston Society of Clinical Pathologists 58 th Annual Spring Symposium Houston, TX April 8, 2017 Jesse K. McKenney, MD Classification
More informationTreatment options for the precancerous Atypical Breast lesions. Prof. YOUNG-JIN SUH The Catholic University of Korea
Treatment options for the precancerous Atypical Breast lesions Prof. YOUNG-JIN SUH The Catholic University of Korea Not so benign lesions? Imaging abnormalities(10% recall) lead to diagnostic evaluation,
More informationACCME/Disclosures ALK FUSION-POSITIVE MESENCHYMAL TUMORS. Tumor types with ALK rearrangements. Anaplastic Lymphoma Kinase. Jason L.
Companion Meeting of the International Society of Bone and Soft Tissue Pathology The Evolving Concept of Mesenchymal Tumors ALK FUSION-POSITIVE MESENCHYMAL TUMORS Jason L. Hornick, MD, PhD March 13, 2016
More informationNeoplasias Quisticas del Páncreas
SEAP -Aproximación Práctica a la Patología Gastrointestinal- Madrid, 26 de mayo, 2006 Neoplasias Quisticas del Páncreas Gregory Y. Lauwers, M.D. Director, Service Massachusetts General Hospital Harvard
More informationDISCUSSION: PLGA accounts for about 2% of all salivary gland tumours and occurs almost exclusively in the minor salivary glands.
SWELLING ON THE HARD PALATE PRESENTING AS POLYMORPHOUS LOW GRADE ADENOCARCINOMA: A AND REVIEW OF LITERATURE Swapnil D. Chandekar 1, Sunita S. Dantkale 2, Rahul R. Narkhede 3, Snehal V. Chavhan 4, Khushboo
More informationBenign Mimics of Malignancy in Breast Pathology
Arthur Purdy Stout Society of Surgical Pathologists Companion Meeting Benign Mimics of Malignancy in Breast Pathology Stuart J. Schnitt, M.D. Beth Israel Deaconess Medical Center and Harvard Medical School,
More informationDIAGNOSTIC SLIDE SEMINAR: PART 1 RENAL TUMOUR BIOPSY CASES
DIAGNOSTIC SLIDE SEMINAR: PART 1 RENAL TUMOUR BIOPSY CASES Dr. Andrew J. Evans MD, PhD, FACP, FRCPC Consultant in Genitourinary Pathology University Health Network, Toronto, ON Case 1 43 year-old female,
More informationXXV Congreso de la Sociedad Española de Anatomía Patológica y División Española de la International Academy of Pathology
XXV Congreso de la Sociedad Española de Anatomía Patológica y División Española de la International Academy of Pathology NUEVOS FENOTIPOS DEL CÁNCER DE MAMA: NUEVOS PROBLEMAS PARA EL PATÓLOGO? Tienen actualmente
More information21/07/2017. Hobnail endothelial cells are not the same as epithelioid endothelial cells
UPDATE IN CUTANEOUS VASCULAR S DERMATOPATHOLOGY SESSION BELFAST PATHOLOGY JUNE 21/2017 Dr E Calonje St John s Institute of Dermatology, London, United Kingdom THE FAMILY OF VASCULAR S WITH EPITHELIOID
More informationLow-grade serous neoplasia. Robert A. Soslow, MD
Low-grade serous neoplasia Robert A. Soslow, MD soslowr@mskcc.org Outline Orientation Ovarian tumor overview Non serous borderline tumors Serous borderline tumors Clinical summary Morphologic description
More informationNon Small Cell Lung Cancer Histopathology ד"ר יהודית זנדבנק
Non Small Cell Lung Cancer Histopathology ד"ר יהודית זנדבנק 26.06.09 Lecture outlines WHO histological classification Macro/Micro assessment Early diagnosis Minimal pathology Main subtypes SCC, AdCa, LCLC
More informationRare Breast Tumours. 1. Breast Tumours. 1.1 General Results. 1.2 Incidence
Rare Breast Tumours 1. Breast Tumours 1.1 General Results Table 1. Epithelial Tumours of Breast: Incidence, Trends, Survival Flemish Region 2001-2010 Incidence Trend Survival Females EAPC Relative survival
More informationCase #1: 75 y/o Male (treated and followed by prostate cancer oncology specialist ).
SOLID TUMORS WORKSHOP Cases for review Prostate Cancer Case #1: 75 y/o Male (treated and followed by prostate cancer oncology specialist ). January 2009 PSA 4.4, 20% free; August 2009 PSA 5.2; Sept 2009
More information57th Annual HSCP Spring Symposium 4/16/2016
An Unusual Malignant Spindle Cell Lesion to Involve the Breast Erinn Downs-Kelly, D.O. Associate Professor of Pathology University of Utah & ARUP Laboratories No disclosures Case 39 y/o female with no
More informationPathology of the Thyroid
Pathology of the Thyroid Thyroid Carcinoma Arising from Follicular Cells 2015-01-19 Prof. Dr. med. Katharina Glatz Pathologie Carcinomas Arising from Follicular Cells Differentiated Carcinoma Papillary
More informationRenal tumours: use of immunohistochemistry & molecular pathology. Dr Lisa Browning John Radcliffe Hospital Oxford
Renal tumours: use of immunohistochemistry & molecular pathology Dr Lisa Browning John Radcliffe Hospital Oxford Renal tumours: the use of immunohistochemistry & molecular pathology Classification of RCC
More informationLesion Imaging Characteristics Mass, Favoring Benign Circumscribed Margins Intramammary Lymph Node
Lesion Imaging Characteristics Mass, Favoring Benign Circumscribed Margins Intramammary Lymph Node Oil Cyst Mass, Intermediate Concern Microlobulated Margins Obscured Margins Mass, Favoring Malignant Indistinct
More informationCN 925/15 History. Microscopic Findings
CN 925/15 History 78 year old female. FNA indeterminate lesion right thyroid lobe. Previous THY1C (UK) Bethesda category 1 cyst fluid. Ultrasound showed part solid/cystic changes, indeterminate in nature
More informationEducational Cases EQA November T.J. Palmer Raigmore Hospital Inverness
Educational Cases EQA November 2013 T.J. Palmer Raigmore Hospital Inverness Case 2 Clinical Details Dob 11 February 1951 PMH: 1964 Extraction of 45 aet 13 yr 1966 Cyst between 44 and 46 enucleated 1973
More informationCASE year old male with a PET avid nodule in the left adrenal gland
CASE 1 55 year old male with a PET avid nodule in the left adrenal gland Case 1 Adrenal gland parenchyma partly replaced by a spindle cell tumour with mild nuclear pleomorphism Atypical mitoses present
More information(CYLINDROMA) ATLAS OF HEAD AND NECK PATHOLOGY ADENOID CYSTIC CARCINOMA
(CYLINDROMA) This malignant tumor is poorly encapsulated and while seemingly well defined within the affected gland, there is usually infiltration of surrounding tissue on closer examination. The cut surface
More information3/27/2017. Pulmonary Pathology Specialty Conference. Disclosure of Relevant Financial Relationships. Clinical History:
Pulmonary Pathology Specialty Conference Saul Suster, M.D. Medical College of Wisconsin Disclosure of Relevant Financial Relationships USCAP requires that all planners (Education Committee) in a position
More informationTHYMIC CARCINOMAS AN UPDATE
THYMIC CARCINOMAS AN UPDATE Mark R. Wick, M.D. University of Virginia Medical Center Charlottesville, VA CARCINOMA OF THE THYMUS General Clinical Features No apparent gender predilection Age range of 35-75
More informationHISTOMORPHOLOGICAL SPECTRUM OF BREAST LESIONS
HISTOMORPHOLOGICAL SPECTRUM OF BREAST LESIONS Kiran H. S, Jayaprakash Shetty, Chandrika Rao Assistant Professor, Department of Pathology, Yenepoya Medical College, Mangalore. Professor, Department of Pathology,
More information6/3/2010. Outline of Talk. Lobular Breast Cancer: Definition of lobular differentiation. Common Problems in Diagnosing LCIS in Core Biopsies
Outline of Talk Lobular Breast Cancer: Common Problems in Diagnosing LCIS in Core Biopsies Definition of lobular differentiation Variants of LCIS that: carry risk for unsampled invasive cancer mimic DCIS
More informationEpithelial Columnar Breast Lesions: Histopathology and Molecular Markers
29th Annual International Conference Advances in the Application of Monoclonal Antibodies in Clinical Oncology and Symposium on Cancer Stem Cells 25 th -27t h June, 2012, Mykonos, Greece Epithelial Columnar
More information